Drug-eluting stents: from bench-top to clinical research

Mounir Welson Zakhary Basalus

doi:10.3990/1.9789461085061

Drug-eluting stents: from bench-top to clinical research

Mounir Welson Zakhary Basalus

Faculty of Behavioural, Management and Social Sciences

Research output: Thesis › PhD Thesis - Research external, graduation UT

218 Downloads (Pure)

Abstract

The development of drug-eluting stents (DES) has improved the invasive treatment of obstructive coronary artery disease by reducing both, restenosis rate and need for reinterventions. This success resulted in a widespread utilization of DES in clinical practice and entailed many clinical research programs. In addition, numerous laboratory examinations of DES have been performed. The majority of this in vitro and pre-clinical research was performed by the DES-developing companies. Only occasionally such data are fully accessible for the public.

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	University of Twente
Supervisors/Advisors	von Birgelen, Clemens, Supervisor
Award date	11 Oct 2013
Place of Publication	Enschede
Publisher	University of Twente
Print ISBNs	978-94-6108-506-1
DOIs	https://doi.org/10.3990/1.9789461085061
Publication status	Published - 11 Oct 2013

Access to Document

10.3990/1.9789461085061

Thesis M.W.Z. BasalusFinal published version, 16.1 MB

Cite this

@phdthesis{41af4a405fde4c91aea88e7bcad6c4ed,

title = "Drug-eluting stents: from bench-top to clinical research",

abstract = "The development of drug-eluting stents (DES) has improved the invasive treatment of obstructive coronary artery disease by reducing both, restenosis rate and need for reinterventions. This success resulted in a widespread utilization of DES in clinical practice and entailed many clinical research programs. In addition, numerous laboratory examinations of DES have been performed. The majority of this in vitro and pre-clinical research was performed by the DES-developing companies. Only occasionally such data are fully accessible for the public.",

author = "Basalus, {Mounir Welson Zakhary}",

year = "2013",

month = oct,

day = "11",

doi = "10.3990/1.9789461085061",

language = "English",

isbn = "978-94-6108-506-1",

publisher = "University of Twente",

address = "Netherlands",

school = "University of Twente",

}

TY - THES

T1 - Drug-eluting stents

T2 - from bench-top to clinical research

AU - Basalus, Mounir Welson Zakhary

PY - 2013/10/11

Y1 - 2013/10/11

N2 - The development of drug-eluting stents (DES) has improved the invasive treatment of obstructive coronary artery disease by reducing both, restenosis rate and need for reinterventions. This success resulted in a widespread utilization of DES in clinical practice and entailed many clinical research programs. In addition, numerous laboratory examinations of DES have been performed. The majority of this in vitro and pre-clinical research was performed by the DES-developing companies. Only occasionally such data are fully accessible for the public.

AB - The development of drug-eluting stents (DES) has improved the invasive treatment of obstructive coronary artery disease by reducing both, restenosis rate and need for reinterventions. This success resulted in a widespread utilization of DES in clinical practice and entailed many clinical research programs. In addition, numerous laboratory examinations of DES have been performed. The majority of this in vitro and pre-clinical research was performed by the DES-developing companies. Only occasionally such data are fully accessible for the public.

U2 - 10.3990/1.9789461085061

DO - 10.3990/1.9789461085061

M3 - PhD Thesis - Research external, graduation UT

SN - 978-94-6108-506-1

PB - University of Twente

CY - Enschede

ER -

Drug-eluting stents: from bench-top to clinical research

Abstract

Access to Document

Fingerprint

Cite this